Market Analysis and Insights: Global RNAi Technologies Market
The research report studies the RNAi Technologies market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global RNAi Technologies market size is projected to reach US$ 430.3 million by 2027, from US$ 301.3 million in 2020, at a CAGR of 4.8% during 2021-2027.
Global RNAi Technologies Scope and Segment
The global RNAi Technologies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global RNAi Technologies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
by Type, the market is primarily split into
Oncology
Ocular Disorders
Respiratory Disorders
Liver Diseases
Other
by Application, this report covers the following segments
Research
Therapeutics
Global RNAi Technologies market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The RNAi Technologies key players in this market include:
Alnylam Pharmaceuticals
Benitec Biopharma Ltd
Filmtec Corporation
Ionis Pharmaceuticals
Quark Pharmaceuticals Inc.
RXI Pharmaceuticals
Qiagen
Invitrogen
Ambion
The research report studies the RNAi Technologies market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global RNAi Technologies market size is projected to reach US$ 430.3 million by 2027, from US$ 301.3 million in 2020, at a CAGR of 4.8% during 2021-2027.
Global RNAi Technologies Scope and Segment
The global RNAi Technologies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global RNAi Technologies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
by Type, the market is primarily split into
Oncology
Ocular Disorders
Respiratory Disorders
Liver Diseases
Other
by Application, this report covers the following segments
Research
Therapeutics
Global RNAi Technologies market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The RNAi Technologies key players in this market include:
Alnylam Pharmaceuticals
Benitec Biopharma Ltd
Filmtec Corporation
Ionis Pharmaceuticals
Quark Pharmaceuticals Inc.
RXI Pharmaceuticals
Qiagen
Invitrogen
Ambion
1 Market Overview of RNAi Technologies
1.1 RNAi Technologies Market Overview
1.1.1 RNAi Technologies Product Scope
1.1.2 RNAi Technologies Market Status and Outlook
1.2 Global RNAi Technologies Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global RNAi Technologies Market Size by Region (2016-2027)
1.4 Global RNAi Technologies Historic Market Size by Region (2016-2021)
1.5 Global RNAi Technologies Market Size Forecast by Region (2022-2027)
1.6 Key Regions, RNAi Technologies Market Size (2016-2027)
1.6.1 North America RNAi Technologies Market Size (2016-2027)
1.6.2 Europe RNAi Technologies Market Size (2016-2027)
1.6.3 Asia-Pacific RNAi Technologies Market Size (2016-2027)
1.6.4 Latin America RNAi Technologies Market Size (2016-2027)
1.6.5 Middle East & Africa RNAi Technologies Market Size (2016-2027)
2 RNAi Technologies Market Overview by Type
2.1 Global RNAi Technologies Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global RNAi Technologies Historic Market Size by Type (2016-2021)
2.3 Global RNAi Technologies Forecasted Market Size by Type (2022-2027)
2.4 Oncology
2.5 Ocular Disorders
2.6 Respiratory Disorders
2.7 Liver Diseases
2.8 Other
3 RNAi Technologies Market Overview by Application
3.1 Global RNAi Technologies Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global RNAi Technologies Historic Market Size by Application (2016-2021)
3.3 Global RNAi Technologies Forecasted Market Size by Application (2022-2027)
3.4 Research
3.5 Therapeutics
4 RNAi Technologies Competition Analysis by Players
4.1 Global RNAi Technologies Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in RNAi Technologies as of 2020)
4.3 Date of Key Players Enter into RNAi Technologies Market
4.4 Global Top Players RNAi Technologies Headquarters and Area Served
4.5 Key Players RNAi Technologies Product Solution and Service
4.6 Competitive Status
4.6.1 RNAi Technologies Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Alnylam Pharmaceuticals
5.1.1 Alnylam Pharmaceuticals Profile
5.1.2 Alnylam Pharmaceuticals Main Business
5.1.3 Alnylam Pharmaceuticals RNAi Technologies Products, Services and Solutions
5.1.4 Alnylam Pharmaceuticals RNAi Technologies Revenue (US$ Million) & (2016-2021)
5.1.5 Alnylam Pharmaceuticals Recent Developments
5.2 Benitec Biopharma Ltd
5.2.1 Benitec Biopharma Ltd Profile
5.2.2 Benitec Biopharma Ltd Main Business
5.2.3 Benitec Biopharma Ltd RNAi Technologies Products, Services and Solutions
5.2.4 Benitec Biopharma Ltd RNAi Technologies Revenue (US$ Million) & (2016-2021)
5.2.5 Benitec Biopharma Ltd Recent Developments
5.3 Filmtec Corporation
5.3.1 Filmtec Corporation Profile
5.3.2 Filmtec Corporation Main Business
5.3.3 Filmtec Corporation RNAi Technologies Products, Services and Solutions
5.3.4 Filmtec Corporation RNAi Technologies Revenue (US$ Million) & (2016-2021)
5.3.5 Ionis Pharmaceuticals Recent Developments
5.4 Ionis Pharmaceuticals
5.4.1 Ionis Pharmaceuticals Profile
5.4.2 Ionis Pharmaceuticals Main Business
5.4.3 Ionis Pharmaceuticals RNAi Technologies Products, Services and Solutions
5.4.4 Ionis Pharmaceuticals RNAi Technologies Revenue (US$ Million) & (2016-2021)
5.4.5 Ionis Pharmaceuticals Recent Developments
5.5 Quark Pharmaceuticals Inc.
5.5.1 Quark Pharmaceuticals Inc. Profile
5.5.2 Quark Pharmaceuticals Inc. Main Business
5.5.3 Quark Pharmaceuticals Inc. RNAi Technologies Products, Services and Solutions
5.5.4 Quark Pharmaceuticals Inc. RNAi Technologies Revenue (US$ Million) & (2016-2021)
5.5.5 Quark Pharmaceuticals Inc. Recent Developments
5.6 RXI Pharmaceuticals
5.6.1 RXI Pharmaceuticals Profile
5.6.2 RXI Pharmaceuticals Main Business
5.6.3 RXI Pharmaceuticals RNAi Technologies Products, Services and Solutions
5.6.4 RXI Pharmaceuticals RNAi Technologies Revenue (US$ Million) & (2016-2021)
5.6.5 RXI Pharmaceuticals Recent Developments
5.7 Qiagen
5.7.1 Qiagen Profile
5.7.2 Qiagen Main Business
5.7.3 Qiagen RNAi Technologies Products, Services and Solutions
5.7.4 Qiagen RNAi Technologies Revenue (US$ Million) & (2016-2021)
5.7.5 Qiagen Recent Developments
5.8 Invitrogen
5.8.1 Invitrogen Profile
5.8.2 Invitrogen Main Business
5.8.3 Invitrogen RNAi Technologies Products, Services and Solutions
5.8.4 Invitrogen RNAi Technologies Revenue (US$ Million) & (2016-2021)
5.8.5 Invitrogen Recent Developments
5.9 Ambion
5.9.1 Ambion Profile
5.9.2 Ambion Main Business
5.9.3 Ambion RNAi Technologies Products, Services and Solutions
5.9.4 Ambion RNAi Technologies Revenue (US$ Million) & (2016-2021)
5.9.5 Ambion Recent Developments
6 North America
6.1 North America RNAi Technologies Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe RNAi Technologies Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific RNAi Technologies Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America RNAi Technologies Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa RNAi Technologies Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 RNAi Technologies Market Dynamics
11.1 RNAi Technologies Industry Trends
11.2 RNAi Technologies Market Drivers
11.3 RNAi Technologies Market Challenges
11.4 RNAi Technologies Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
1.1 RNAi Technologies Market Overview
1.1.1 RNAi Technologies Product Scope
1.1.2 RNAi Technologies Market Status and Outlook
1.2 Global RNAi Technologies Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global RNAi Technologies Market Size by Region (2016-2027)
1.4 Global RNAi Technologies Historic Market Size by Region (2016-2021)
1.5 Global RNAi Technologies Market Size Forecast by Region (2022-2027)
1.6 Key Regions, RNAi Technologies Market Size (2016-2027)
1.6.1 North America RNAi Technologies Market Size (2016-2027)
1.6.2 Europe RNAi Technologies Market Size (2016-2027)
1.6.3 Asia-Pacific RNAi Technologies Market Size (2016-2027)
1.6.4 Latin America RNAi Technologies Market Size (2016-2027)
1.6.5 Middle East & Africa RNAi Technologies Market Size (2016-2027)
2 RNAi Technologies Market Overview by Type
2.1 Global RNAi Technologies Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global RNAi Technologies Historic Market Size by Type (2016-2021)
2.3 Global RNAi Technologies Forecasted Market Size by Type (2022-2027)
2.4 Oncology
2.5 Ocular Disorders
2.6 Respiratory Disorders
2.7 Liver Diseases
2.8 Other
3 RNAi Technologies Market Overview by Application
3.1 Global RNAi Technologies Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global RNAi Technologies Historic Market Size by Application (2016-2021)
3.3 Global RNAi Technologies Forecasted Market Size by Application (2022-2027)
3.4 Research
3.5 Therapeutics
4 RNAi Technologies Competition Analysis by Players
4.1 Global RNAi Technologies Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in RNAi Technologies as of 2020)
4.3 Date of Key Players Enter into RNAi Technologies Market
4.4 Global Top Players RNAi Technologies Headquarters and Area Served
4.5 Key Players RNAi Technologies Product Solution and Service
4.6 Competitive Status
4.6.1 RNAi Technologies Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Alnylam Pharmaceuticals
5.1.1 Alnylam Pharmaceuticals Profile
5.1.2 Alnylam Pharmaceuticals Main Business
5.1.3 Alnylam Pharmaceuticals RNAi Technologies Products, Services and Solutions
5.1.4 Alnylam Pharmaceuticals RNAi Technologies Revenue (US$ Million) & (2016-2021)
5.1.5 Alnylam Pharmaceuticals Recent Developments
5.2 Benitec Biopharma Ltd
5.2.1 Benitec Biopharma Ltd Profile
5.2.2 Benitec Biopharma Ltd Main Business
5.2.3 Benitec Biopharma Ltd RNAi Technologies Products, Services and Solutions
5.2.4 Benitec Biopharma Ltd RNAi Technologies Revenue (US$ Million) & (2016-2021)
5.2.5 Benitec Biopharma Ltd Recent Developments
5.3 Filmtec Corporation
5.3.1 Filmtec Corporation Profile
5.3.2 Filmtec Corporation Main Business
5.3.3 Filmtec Corporation RNAi Technologies Products, Services and Solutions
5.3.4 Filmtec Corporation RNAi Technologies Revenue (US$ Million) & (2016-2021)
5.3.5 Ionis Pharmaceuticals Recent Developments
5.4 Ionis Pharmaceuticals
5.4.1 Ionis Pharmaceuticals Profile
5.4.2 Ionis Pharmaceuticals Main Business
5.4.3 Ionis Pharmaceuticals RNAi Technologies Products, Services and Solutions
5.4.4 Ionis Pharmaceuticals RNAi Technologies Revenue (US$ Million) & (2016-2021)
5.4.5 Ionis Pharmaceuticals Recent Developments
5.5 Quark Pharmaceuticals Inc.
5.5.1 Quark Pharmaceuticals Inc. Profile
5.5.2 Quark Pharmaceuticals Inc. Main Business
5.5.3 Quark Pharmaceuticals Inc. RNAi Technologies Products, Services and Solutions
5.5.4 Quark Pharmaceuticals Inc. RNAi Technologies Revenue (US$ Million) & (2016-2021)
5.5.5 Quark Pharmaceuticals Inc. Recent Developments
5.6 RXI Pharmaceuticals
5.6.1 RXI Pharmaceuticals Profile
5.6.2 RXI Pharmaceuticals Main Business
5.6.3 RXI Pharmaceuticals RNAi Technologies Products, Services and Solutions
5.6.4 RXI Pharmaceuticals RNAi Technologies Revenue (US$ Million) & (2016-2021)
5.6.5 RXI Pharmaceuticals Recent Developments
5.7 Qiagen
5.7.1 Qiagen Profile
5.7.2 Qiagen Main Business
5.7.3 Qiagen RNAi Technologies Products, Services and Solutions
5.7.4 Qiagen RNAi Technologies Revenue (US$ Million) & (2016-2021)
5.7.5 Qiagen Recent Developments
5.8 Invitrogen
5.8.1 Invitrogen Profile
5.8.2 Invitrogen Main Business
5.8.3 Invitrogen RNAi Technologies Products, Services and Solutions
5.8.4 Invitrogen RNAi Technologies Revenue (US$ Million) & (2016-2021)
5.8.5 Invitrogen Recent Developments
5.9 Ambion
5.9.1 Ambion Profile
5.9.2 Ambion Main Business
5.9.3 Ambion RNAi Technologies Products, Services and Solutions
5.9.4 Ambion RNAi Technologies Revenue (US$ Million) & (2016-2021)
5.9.5 Ambion Recent Developments
6 North America
6.1 North America RNAi Technologies Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe RNAi Technologies Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific RNAi Technologies Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America RNAi Technologies Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa RNAi Technologies Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 RNAi Technologies Market Dynamics
11.1 RNAi Technologies Industry Trends
11.2 RNAi Technologies Market Drivers
11.3 RNAi Technologies Market Challenges
11.4 RNAi Technologies Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
